1. Home
  2. VSAT vs NVCR Comparison

VSAT vs NVCR Comparison

Compare VSAT & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ViaSat Inc.

VSAT

ViaSat Inc.

HOLD

Current Price

$36.38

Market Cap

4.6B

Sector

Technology

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$13.61

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSAT
NVCR
Founded
1986
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
1.5B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
VSAT
NVCR
Price
$36.38
$13.61
Analyst Decision
Buy
Buy
Analyst Count
7
6
Target Price
$33.00
$28.42
AVG Volume (30 Days)
1.8M
1.9M
Earning Date
02-05-2026
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,582,796,000.00
$642,269,000.00
Revenue This Year
$5.21
$9.75
Revenue Next Year
$3.22
$5.62
P/E Ratio
N/A
N/A
Revenue Growth
1.23
11.17
52 Week Low
$7.36
$10.70
52 Week High
$43.59
$32.06

Technical Indicators

Market Signals
Indicator
VSAT
NVCR
Relative Strength Index (RSI) 53.95 60.85
Support Level $32.06 $12.30
Resistance Level $38.66 $13.94
Average True Range (ATR) 2.03 0.61
MACD -0.08 0.09
Stochastic Oscillator 62.35 87.66

Price Performance

Historical Comparison
VSAT
NVCR

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: